Literature DB >> 18297277

Distribution of parvalbumin and calretinin immunoreactive interneurons in motor cortex from multiple sclerosis post-mortem tissue.

Robert J Clements1, Jennifer McDonough, Ernest J Freeman.   

Abstract

Parvalbumin (PV) and calretinin (CR) are calcium binding proteins (CBP's) expressed in discrete GABAergic interneuron populations in the human cortex. CBP's are known to buffer calcium concentrations and protect neurons from increases in intracellular calcium. Perturbations in intracellular calcium can activate proteolytic enzymes including calpain, leading to deleterious effects to axons. Ca++-mediated mechanisms have been found to be associated with axonal pathology in MS and the restructuring of calcium channels has been shown to occur in experimental autoimmune encephalomyelitis (EAE) as well as multiple sclerosis tissue. Previous data indicates a reduction in the expression of the parvalbumin gene as well as reduced extension of neurites on parvalbumin expressing interneurons within multiple sclerosis normal appearing grey matter (NAGM). Modifications in interneuron parvalbumin or calretinin levels could change calcium buffering capacity, as well as the way these cells respond to neuronal insults. The present study was designed to compare CBP immunoreactive neurons in normal and multiple sclerosis post-mortem NAGM. To this end, we utilized immunofluorescent staining and high resolution confocal microscopy to map regions of the human motor cortex, and characterize layer specific CBP distribution in the normal and multiple sclerosis motor cortex. Our results indicate a significant reduction in the number of PV interneurons within layer 2 of the multiple sclerosis primary motor cortex with no concurrent change in number of calretinin positive neurons.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18297277     DOI: 10.1007/s00221-008-1317-9

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  24 in total

Review 1.  Neuronal calcium-binding proteins and schizophrenia.

Authors:  D W Eyles; J J McGrath; G P Reynolds
Journal:  Schizophr Res       Date:  2002-09-01       Impact factor: 4.939

2.  Brain excitability changes in the relapsing and remitting phases of multiple sclerosis: a study with transcranial magnetic stimulation.

Authors:  M Donatella Caramia; M Giuseppina Palmieri; M Teresa Desiato; Laura Boffa; Pierluigi Galizia; Paolo M Rossini; Diego Centonze; Giorgio Bernardi
Journal:  Clin Neurophysiol       Date:  2004-04       Impact factor: 3.708

Review 3.  Types of neurons, synaptic connections and chemical characteristics of cells immunoreactive for calbindin-D28K, parvalbumin and calretinin in the neocortex.

Authors:  J DeFelipe
Journal:  J Chem Neuroanat       Date:  1997-12       Impact factor: 3.052

4.  Colocalization of parvalbumin and calbindin D-28k in neurons including chandelier cells of the human temporal neocortex.

Authors:  M R del Río; J DeFelipe
Journal:  J Chem Neuroanat       Date:  1997-03       Impact factor: 3.052

5.  The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia.

Authors:  David Cotter; Sabine Landau; Clare Beasley; Robert Stevenson; Gursharon Chana; Laura MacMillan; Ian Everall
Journal:  Biol Psychiatry       Date:  2002-03-01       Impact factor: 13.382

6.  Motor cortex excitability and fatigue in multiple sclerosis: a transcranial magnetic stimulation study.

Authors:  J Liepert; D Mingers; C Heesen; T Bäumer; C Weiller
Journal:  Mult Scler       Date:  2005-06       Impact factor: 6.312

7.  Co-localization of sodium channel Nav1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE.

Authors:  Matthew J Craner; Bryan C Hains; Albert C Lo; Joel A Black; Stephen G Waxman
Journal:  Brain       Date:  2003-12-08       Impact factor: 13.501

8.  Over-expression of parvalbumin in transgenic mice rescues motoneurons from injury-induced cell death.

Authors:  J Dekkers; P Bayley; J R T Dick; B Schwaller; M W Berchtold; L Greensmith
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

9.  15N NMR relaxation studies of calcium-loaded parvalbumin show tight dynamics compared to those of other EF-hand proteins.

Authors:  C Baldellon; J R Alattia; M P Strub; T Pauls; M W Berchtold; A Cavé; A Padilla
Journal:  Biochemistry       Date:  1998-07-14       Impact factor: 3.162

10.  Brain atrophy in clinically early relapsing-remitting multiple sclerosis.

Authors:  D T Chard; C M Griffin; G J M Parker; R Kapoor; A J Thompson; D H Miller
Journal:  Brain       Date:  2002-02       Impact factor: 13.501

View more
  19 in total

1.  Calpeptin attenuated inflammation, cell death, and axonal damage in animal model of multiple sclerosis.

Authors:  M Kelly Guyton; Arabinda Das; Supriti Samantaray; Gerald C Wallace; Jonathan T Butler; Swapan K Ray; Naren L Banik
Journal:  J Neurosci Res       Date:  2010-08-15       Impact factor: 4.164

2.  Enhanced GABAergic Tonic Inhibition Reduces Intrinsic Excitability of Hippocampal CA1 Pyramidal Cells in Experimental Autoimmune Encephalomyelitis.

Authors:  Laura G Kammel; Weizheng Wei; Shekib A Jami; Rhonda R Voskuhl; Thomas J O'Dell
Journal:  Neuroscience       Date:  2018-11-14       Impact factor: 3.590

Review 3.  The immunopathophysiology of multiple sclerosis.

Authors:  Gregory F Wu; Enrique Alvarez
Journal:  Neurol Clin       Date:  2011-05       Impact factor: 3.806

Review 4.  Cognitive deficits in experimental autoimmune encephalomyelitis: neuroinflammation and synaptic degeneration.

Authors:  G Mandolesi; G Grasselli; G Musumeci; Diego Centonze
Journal:  Neurol Sci       Date:  2010-11       Impact factor: 3.307

Review 5.  Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis.

Authors:  Robert Nisticò; Francesco Mori; Marco Feligioni; Ferdinando Nicoletti; Diego Centonze
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-12-02       Impact factor: 6.237

6.  Interleukin-1β alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis.

Authors:  Georgia Mandolesi; Alessandra Musella; Antonietta Gentile; Giorgio Grasselli; Nabila Haji; Helena Sepman; Diego Fresegna; Silvia Bullitta; Francesca De Vito; Gabriele Musumeci; Claudio Di Sanza; Piergiorgio Strata; Diego Centonze
Journal:  J Neurosci       Date:  2013-07-17       Impact factor: 6.167

7.  Reduced GABA levels correlate with cognitive impairment in patients with relapsing-remitting multiple sclerosis.

Authors:  Guanmei Cao; Richard A E Edden; Fei Gao; Hao Li; Tao Gong; Weibo Chen; Xiaohui Liu; Guangbin Wang; Bin Zhao
Journal:  Eur Radiol       Date:  2017-10-06       Impact factor: 5.315

Review 8.  Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis.

Authors:  Georgia Mandolesi; Antonietta Gentile; Alessandra Musella; Diego Fresegna; Francesca De Vito; Silvia Bullitta; Helena Sepman; Girolama A Marfia; Diego Centonze
Journal:  Nat Rev Neurol       Date:  2015-11-20       Impact factor: 42.937

9.  Mitochondrial changes within axons in multiple sclerosis.

Authors:  Don J Mahad; Iryna Ziabreva; Graham Campbell; Nichola Lax; Katherine White; Peter S Hanson; Hans Lassmann; Douglass M Turnbull
Journal:  Brain       Date:  2009-03-17       Impact factor: 13.501

10.  Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis.

Authors:  Robert Nisticò; Dalila Mango; Georgia Mandolesi; Sonia Piccinin; Nicola Berretta; Marco Pignatelli; Marco Feligioni; Alessandra Musella; Antonietta Gentile; Francesco Mori; Giorgio Bernardi; Ferdinando Nicoletti; Nicola B Mercuri; Diego Centonze
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.